What the state record says
New Jersey’s September 2026 scheduling alert covers mitragynine pseudoindoxyl, MGM-15 and MGM-16, which are different compounds from 7OH. A separate Senate proposal, S301, would put 7OH in Schedule I. A committee’s favorable report does not enact that proposal.
State-level summary; federal law and local ordinances apply separately.
Mitragynine pseudoindoxyl, MGM-15 and MGM-16 are distinct from 7OH. An announcement scheduling those compounds should not be used as evidence that the separate 7OH proposal has also become law.
Upcoming changes & open questions
The Senate Health Committee reported S301 favorably March 16, 2026. This review did not confirm a signed act scheduling 7OH under that bill; continue checking its legislative history.
How to use this entry
Check whether the source covers possession, manufacturing, distribution or sale. Read its definitions of kratom products, synthetic alkaloids and 7-hydroxymitragynine. Concentration limits may use different denominators: a percentage of total alkaloids is not the same as a percentage of dry weight.
Verify the effective date and any amendments, temporary rules, court orders or local restrictions. A retailer’s shipping options do not establish legality.
Original sources
- New Jersey Attorney General: September scheduling alert
- New Jersey Senate: S301 committee statement
- New Jersey Legislature: S301 bill record
Federal rules apply too
State treatment and federal treatment are separate. Follow our federal scheduling brief and the live agency records before relying on a state summary.